Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren’s syndrome

1. VITALI C., BOMBARDIERI S., JONSSON R., MOUTSOPOULOS HM., ALEXANDER EL., CARSONS SE., et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.10.1136/ard.61.6.554175413712006334Search in Google Scholar

2. ALANI H., HENTY JR., THOMPSON NL., JURY E., CIURTIN C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47(2):141–54.10.1080/03009742.2017.132490928927315Search in Google Scholar

3. BROWN LE., FRITS ML., IANNACCONE CK., WEINBLATT ME., SHADICK NA., LIAO KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford). 2015;54(5):816–20.10.1093/rheumatology/keu400441608325313147Search in Google Scholar

4. KIM SM., PARK E., LEE JH., LEE SH., KIM HR. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome. Rheumatol Int. 2012;32(12):3963–7.10.1007/s00296-011-2274-322205381Search in Google Scholar

5. LEE J., KOH JH., KIM JW., SUNG YK., LEE SS., CHOE JY., et al. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren’s syndrome in a Korean cohort. Rheumatol Int. 2018;38(9):1651–60.10.1007/s00296-018-4109-y30030624Search in Google Scholar

6. TEN BRINCK RM., VAN STEENBERGEN HW., VAN DELFT MAM., VERHEUL MK., TOES REM., TROUW LA., et al. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia. Rheumatology (Oxford). 2017;56(12):2145–53.10.1093/rheumatology/kex340670399728968865Search in Google Scholar

7. NISHIMURA K., SUGIYAMA D., KOGATA Y., TSUJI G., NAKAZAWA T., KAWANO S., et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808.10.7326/0003-4819-146-11-200706050-0000817548411Search in Google Scholar

8. PERRY E., KELLY C., EGGLETON P., DE SOYZA A., HUTCHINSON D. The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology (Oxford). 2014;53(11):1940–50.10.1093/rheumatology/keu19524831057Search in Google Scholar

9. LAPPIN DF., APATZIDOU D., QUIRKE AM., OLIVER-BELL J., BUTCHER JP., KINANE DF., et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol. 2013;40(10):907–15.10.1111/jcpe.1213823902301Search in Google Scholar

10. MARESZ KJ., HELLVARD A., SROKA A., ADAMOWICZ K., BIELECKA E., KOZIEL J., et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013;9(9):e1003627.10.1371/journal.ppat.1003627377190224068934Search in Google Scholar

11. HUTCHINSON D., SHEPSTONE L., MOOTS R., LEAR JT., LYNCH MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001;60(3):223–7.10.1136/ard.60.3.223Search in Google Scholar

12. KALLBERG H., DING B., PADYUKOV L., BENGTSSON C., RONNELID J., KLARESKOG L., et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70(3):508–11.10.1136/ard.2009.120899Search in Google Scholar

13. MAKRYGIANNAKIS D., HERMANSSON M., ULFGREN AK., NICHOLAS AP., ZENDMAN AJ., EKLUND A., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–92.10.1136/ard.2007.075192Search in Google Scholar

14. KLARESKOG L., STOLT P., LUNDBERG K., KALLBERG H., BENGTSSON C., GRUNEWALD J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46.10.1002/art.21575Search in Google Scholar

15. KLARESKOG L., RONNELID J., LUNDBERG K., PADYUKOV L., ALFREDSSON L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26:651–75.10.1146/annurev.immunol.26.021607.090244Search in Google Scholar

16. RUIZ-ESQUIDE V., GOMARA MJ., PEINADO VI., GOMEZ PUERTA JA., BARBERA JA., CANETE JDE D., et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31(7):1047–50.10.1007/s10067-012-1971-ySearch in Google Scholar

17. PABST R., GEHRKE I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol. 1990;3(2):131–5.10.1165/ajrcmb/3.2.131Search in Google Scholar

18. PABST R. Is BALT a major component of the human lung immune system? Immunol Today. 1992;13(4):119–22.10.1016/0167-5699(92)90106-HSearch in Google Scholar

19. RANGEL-MORENO J., HARTSON L., NAVARRO C., GAXIOLA M., SELMAN M., RANDALL TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183–94.10.1172/JCI28756167882017143328Search in Google Scholar

20. BAKA Z., GYORGY B., GEHER P., BUZAS EI., FALUS A., NAGY G. Citrullination under physiological and pathological conditions. Joint Bone Spine. 2012;79(5):431–6.10.1016/j.jbspin.2012.01.00822366145Search in Google Scholar

21. KAWAHITO Y., ICHINOSE S., SANO H., TSUBOUCHI Y., KOHNO M., YOSHIKAWA T., et al. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis. Biochem Biophys Res Commun. 2008;369(2):561–6.10.1016/j.bbrc.2008.02.07918307980Search in Google Scholar